EU’s ability to challenge ‘killer acquisitions’ dealt a blow by Europe’s highest court

Illumina, a global leader in DNA sequencing technologies, has won a battle against the EU over its decision to block the merger between it and Grail, a company specialising in early cancer detection through genetic diagnostics.